Induction of amplified synthesis and secretion of IgM by fusion of murine 'b lymphoma with myeloma cells.

Publisher Website
Google Scholar
Abstract
Murine B [bone marrow-derived] lymphoma cultured cell lines bearing membrane Ig[immunoglobulin]M and lacking the ability to secrete measurable amounts of IgM were fused with drug-resistant cell lines derived from the IgG2b-producing MPC-11 myeloma. Many of the hybrid clones synthesized and secreted large amounts of IgM, as judged by radial and double immunodiffusion in agar of culture supernatants and by polyacrylamide gel electrophoresis of biosynthetically labeled IgM. When fused with an IgG2b-producing myeloma, many of the hybrids produced IgG2b, indicating that there was no suppression of the parental IgG synthesis in the hybrids. The amount of IgM or IgG2b secreted by the hybrids was higher than that secreted by myeloma cell lines. The synthesis of the .gamma.2b H chain of the MPC-11 myeloma was not reexpressed by fusion of a .gamma.2b nonproducer myeloma cell variant with B lymphoma. No other classes of Ig H chains, besides the .gamma.2b and the .mu. chains, were secreted by any of more than 100 B lymphoma-myeloma hybrids examined. Myeloma cells may fuse with normal plasma cells and with less-mature normal B lymphocytes. This fusion may induce the maturation of B lymphocytes into IgM-secreting cells.